Mr. Speaker, to my hon. colleague, those hearings were very important in terms of shedding light on what is happening. It is important to note that it was identified that the government has not done nearly enough. I can point to some media reports. If people are interested they can go to politicswatch.com which has been covering this story. It has identified quite rightly that Canada has not been providing the proper support. In fact, there has only been mild promotion and a web page. That is what has been happening. The confusion out there is phenomenal.
I would also point out the issues that are being faced. The government has to bring forward immediate changes in its attitude and in the way the policy is being developed.
Stephen Lewis made a presentation to the committee. He was quite right in noting that many countries are not accessing this because of intimidation. We can look at the situation in Thailand which issued a licence itself for a generic drug. That country has been intimidated by the pharmaceuticals with threats of pulling out other types of drugs.
There has also been evidence presented by Oxfam--